David Rees, MA, MBBS, FRCPath, FRCPCH, FRCP - Sickle Cell Disease in Perspective: An Expert Point of View on Therapeutic Selection and Comprehensive Care
12 Sep 2025
Contributed by Lukas
Please visit answersincme.com/GTM860 to participate, download slides and supporting materials, comp...
Mona Shafey, MD, FRCPC / Nicole Lamanna, MD - Charting the Course: Navigating the Maze of Treatment Selection and Sequencing in CLL
12 Sep 2025
Contributed by Lukas
Please visit answersincme.com/860/240201294-replay to participate, download slides and supporting m...
Raffaele Califano, MD / Nicolas Girard, MD, PhD / Antonio Passaro, MD, PhD - Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes
10 Sep 2025
Contributed by Lukas
Please visit answersincme.com/860/98320325-replay to participate, download slides and supporting ma...
Jesus Berdeja, MD - Chartering New Frontiers in Myeloma Care: What Role May Novel CELMoDs Play in Early-Relapse Therapy?
18 Aug 2025
Contributed by Lukas
Please visit answersincme.com/NPK860 to participate, download slides and supporting materials, comp...
Sebastian Stintzing, MD - A Step-by-Step Guide to Metastatic CRC: Strategies to Integrate Anti-EGFR Therapies
13 Aug 2025
Contributed by Lukas
Please visit answersincme.com/FAH860 to participate, download slides and supporting materials, comp...
Daniel Petrylak, MD - Answering Key Questions About Biomarkers in Urothelial Cancer: Guidance for Improving Implementation
31 Jul 2025
Contributed by Lukas
Please visit answersincme.com/HSJ860 to participate, download slides and supporting materials, comp...
Benjamin Levy, MD, FASCO - Keeping Pace With TROP2-Directed ADCs: Their Evolving Role in Advanced, Pretreated EGFR-Mutated NSCLC
29 Jul 2025
Contributed by Lukas
Please visit answersincme.com/PYP860 to participate, download slides and supporting materials, comp...
Luis Paz-Ares, MD, PhD / Niels Reinmuth, MD, PhD - Developing a Master Plan for ES-SCLC: A Practical Guide to Elevate Care in the Real-World
28 Jul 2025
Contributed by Lukas
Please visit answersincme.com/860/97851223-replay1 to participate, download slides and supporting m...
John Marshall, MD - Re-Invigorating the Later-Line Treatment of Metastatic Colorectal Cancer: Practical Strategies to Optimize the Use of Tyrosine Kinase Inhibitors
18 Jul 2025
Contributed by Lukas
Please visit answersincme.com/KTK860 to participate, download slides and supporting materials, comp...
Neil D. Gross, MD, FACS - Evolving the Multi-Modal Approach for Resectable Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Assessment of Current and Emerging Immunotherapeutic Strategies
11 Jul 2025
Contributed by Lukas
Please visit answersincme.com/VJW860 to participate, download slides and supporting materials, comp...
Hussein Tawbi, MD, PhD - Evolving Melanoma Care: The Clinical Impact of Anti-LAG-3/PD-1 Combinations
07 Jul 2025
Contributed by Lukas
Please visit answersincme.com/XWB860 to participate, download slides and supporting materials, comp...
Selim Corbacioglu, MD, PhD - Transforming Transfusion Dependence: Practical Steps for Incorporating Novel Beta Thalassemia Treatments Into Practice
04 Jul 2025
Contributed by Lukas
Please visit answersincme.com/BUS860 to participate, download slides and supporting materials, comp...
Thomas Powles, MBBS, MRCP, MD / Jonathan E. Rosenberg, MD - Advancing Urothelial Carcinoma Care With Multidisciplinary Strategies for Clinical Management
03 Jul 2025
Contributed by Lukas
Please visit answersincme.com/WHF860 to participate, download slides and supporting materials, comp...
Barbara Burtness, MD - The Pan-Tumor Perspective: Looking Toward the Future of Care With HER3-Directed ADCs for Pretreated Patients With Advanced Solid Tumors
01 Jul 2025
Contributed by Lukas
Please visit answersincme.com/DDP860 to participate, download slides and supporting materials, comp...
Mark A. Socinski, MD - Global Perspectives on Biomarker Testing in NSCLC: Clinical Insights on Optimizing Implementation in Practice
24 Jun 2025
Contributed by Lukas
Please visit answersincme.com/ZDE860 to participate, download slides and supporting materials, comp...
Venkataraman Raman Muthusamy, MD, MAS - A Window of Opportunity: Identifying the Risk of Esophageal Adenocarcinoma With Prognostic Testing
23 Jun 2025
Contributed by Lukas
Please visit answersincme.com/URZ860 to participate, download slides and supporting materials, comp...
Aditya Bardia, MD / Joyce O'Shaughnessy, MD - Optimizing Survivorship Across the Patient Journey, Including Lines of Therapy
17 Jun 2025
Contributed by Lukas
Please visit answersincme.com/860/27391-replay3 to participate, download slides and supporting mate...
Aditya Bardia, MD / Giuseppe Curigliano, MD, PhD - Sequencing in the Real World With Complex Patient Types, Including Underrepresented Populations
02 Jun 2025
Contributed by Lukas
Please visit answersincme.com/860/27391-replay2 to participate, download slides and supporting mate...
Aditya Bardia, MD / Joyce O'Shaughnessy, MD - Expert-Guided Approaches to Sequencing Strategies With ADCs in HR+, HER2- mBC
29 May 2025
Contributed by Lukas
Please visit answersincme.com/860/27391-replay1 to participate, download slides and supporting mate...
Jesus G. Berdeja, MD - Optimizing Outcomes in Relapsed/Refractory Multiple Myeloma With Bispecific Antibodies: A Community Clinician's Roadmap
06 May 2025
Contributed by Lukas
Please visit answersincme.com/RJB860 to participate, download slides and supporting materials, comp...
Aditya Bardia, MD / Sara Hurvitz, MD - Making a World of Difference for Patients With HER2-Low and -Ultralow Advanced Breast Cancer: Practical Strategies to Integrate Antibody-Drug Conjugates in Special Populations
16 Apr 2025
Contributed by Lukas
Please visit answersincme.com/860/95483855-replay3 to participate, download slides and supporting m...
Aditya Bardia, MD / Sara Hurvitz, MD - Realizing the Potential of Antibody-Drug Conjugates in HER2-Low and -Ultralow Advanced Breast Cancer: Evolving Strategies to Individualize Care
10 Apr 2025
Contributed by Lukas
Please visit answersincme.com/860/95483855-replay2 to participate, download slides and supporting m...
Komal Jhaveri, MD, FACP - Opportunities to Personalize Care: Making the Case for TROP2-Directed ADCs in HR+, HER2- Metastatic Breast Cancer
10 Apr 2025
Contributed by Lukas
Please visit answersincme.com/BCQ860 to participate, download slides and supporting materials, comp...
Aditya Bardia, MD / Marilyn M. Bui, MD, PhD - Bringing HER2 Low and Ultralow to Light: How to Define and Detect HER2 Status in Advanced Breast Cancer
04 Apr 2025
Contributed by Lukas
Please visit answersincme.com/860/95483855-replay1 to participate, download slides and supporting m...
Thomas Martin, MD - Focusing on the Frontline: The Impact of Anti-CD38-Based Quadruplet Regimens for Transplant-Ineligible, Newly-Diagnosed Myeloma
07 Mar 2025
Contributed by Lukas
Please visit answersincme.com/BCK860 to participate, download slides and supporting materials, comp...
Arvind Dasari, MD - Leveling Up Care in the Later-Line Treatment of Metastatic Colorectal Cancer: Bringing Quality of Life to the Forefront
31 Jan 2025
Contributed by Lukas
Please visit answersincme.com/BPB860 to participate, download slides and supporting materials, comp...
Joshua Richter, MD, FACP - Enhancing Outcomes in Heavily Pretreated Relapsed/Refractory Multiple Myeloma: Harnessing Bispecific Antibodies in Community Care
08 Jan 2025
Contributed by Lukas
Please visit answersincme.com/GPV860 to participate, download slides and supporting materials, comp...
Jorge Cortes, MD / Elias Jabbour, MD - Care Strategies for Chronic Myeloid Leukemia in Chronic Phase: Customizing Frontline TKI Therapy to Optimize Long-term Patient Outcomes
08 Jan 2025
Contributed by Lukas
Please visit answersincme.com/MNK860 to participate, download slides and supporting materials, comp...
Pasi A. Jänne, MD, PhD - Expanding Pathways of Care for HER2-Positive Metastatic NSCLC: Beyond Mutation to Overexpression
02 Jan 2025
Contributed by Lukas
Please visit answersincme.com/GRK860 to participate, download slides and supporting materials, comp...
Aditya Bardia, MD - Keeping Pace With TROP2-Directed ADCs in HR-Positive, HER2-Negative/Low Advanced Breast Cancer
31 Dec 2024
Contributed by Lukas
Please visit answersincme.com/EYY860 to participate, download slides and supporting materials, comp...
Sangini S. Sheth, MD, MPH - The Power of Prevention: Patient-Clinician Insights on Increasing HPV Vaccination Uptake to Reduce Cervical Cancer Risk
27 Dec 2024
Contributed by Lukas
Please visit answersincme.com/JUC860 to participate, download slides and supporting materials, comp...
Sunandana Chandra, MD, MS - Practical Guidance on Managing Adverse Events Associated With Immunotherapy Regimens for Nonmelanoma Skin Cancers
17 Dec 2024
Contributed by Lukas
Please visit answersincme.com/WJM860 to participate, download slides and supporting materials, comp...
Alexander I. Spira, MD, PhD, FACP - Biomarkers at the Forefront: The Crucial Role of Testing Across Solid Tumor Types
13 Dec 2024
Contributed by Lukas
Please visit answersincme.com/SWT860 to participate, download slides and supporting materials, comp...
David Harpole, MD / Alfredo Addeo, MD - The Possibilities of Perioperative: Assessing the Use of Perioperative Immunotherapy for Resectable NSCLC
12 Dec 2024
Contributed by Lukas
Please visit answersincme.com/860/94256783-replay1 to participate, download slides and supporting m...
Jacob Sands, MD / Luis Paz-Ares, MD, PhD - Advancing Care in EGFR-Mutated NSCLC: Unveiling New Horizons With ADCs
02 Dec 2024
Contributed by Lukas
Please visit answersincme.com/860/93496951-replay3 to participate, download slides and supporting m...
David Harpole, MD / Neel Chudgar, MD - The Practicalities of Perioperative Immunotherapy for Resectable NSCLC
26 Nov 2024
Contributed by Lukas
Please visit answersincme.com/860/94256783-replay3 to participate, download slides and supporting m...
David Harpole, MD / Nicolas Girard, MD, PhD - Trials and Tribulations: Examining the Data for Perioperative Immunotherapeutic Approaches in Resectable NSCLC
20 Nov 2024
Contributed by Lukas
Please visit answersincme.com/860/94256783-replay2 to participate, download slides and supporting m...
Jia Ruan, MD, PhD - Clinical Case Challenges in Frontline PTCL: Navigating the Landscape of CD30-Positive PTCL Treatment
15 Nov 2024
Contributed by Lukas
Please visit answersincme.com/BHU860 to participate, download slides and supporting materials, comp...
Jacob Sands, MD / Luis Paz-Ares, MD, PhD - Leveraging Precise Targets to Elevate Outcomes: NSCLC Treatment Strategies for HER2-Directed ADCs
15 Nov 2024
Contributed by Lukas
Please visit answersincme.com/860/93496951-replay2 to participate, download slides and supporting m...
Nikhil I. Khushalani, MD - Practical Guidance for Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: Using Immunotherapy Effectively in Clinical Practice
06 Nov 2024
Contributed by Lukas
Please visit answersincme.com/JZC860 to participate, download slides and supporting materials, comp...
Jacob Sands, MD / Raffaele Califano, MD - Novel ADC Targets in Advanced NSCLC: Examining Emerging Strategies for TROP2-Directed ADCs
30 Oct 2024
Contributed by Lukas
Please visit answersincme.com/93496951-replay1 to participate, download slides and supporting mater...
Richard Kim, MD / Gerald Prager, MD - Evidence-Based Strategies for Optimizing Long-Term Treatment Responses in Later Lines of mCRC Care
28 Oct 2024
Contributed by Lukas
Please visit answersincme.com/TBY860 to participate, download slides and supporting materials, comp...
Vishal A. Patel, MD - Selecting and Sequencing Systemic Treatment for Advanced Basal Cell Carcinoma
28 Oct 2024
Contributed by Lukas
Please visit answersincme.com/UCA860 to participate, download slides and supporting materials, comp...
Joyce O'Shaughnessy, MD - Harnessing Immunotherapy for Early Breast Cancer Management: Neoadjuvant Updates in HR-Positive, HER2-Negative Disease
19 Sep 2024
Contributed by Lukas
Please visit answersincme.com/ZFZ860 to participate, download slides and supporting materials, comp...
Ahmad Tarhini, MD, PhD - Adjuvant Approaches in High-Risk, Resectable Melanoma: A Practical Guide to Improving Outcomes With Immunotherapy-Based Regimens
19 Sep 2024
Contributed by Lukas
Please visit answersincme.com/RKX860 to participate, download slides and supporting materials, comp...
David M. Miller, MD, PhD / Todd Schlesinger, MD - A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies
13 Sep 2024
Contributed by Lukas
Please visit answersincme.com/GEU860 to participate, download slides and supporting materials, comp...
Vasu Divi, MD, MS - Neoadjuvant Immunotherapy for CSCC: Practical Considerations for Resectability, Patient Selection, and Treatment Optimization
09 Sep 2024
Contributed by Lukas
Please visit answersincme.com/GWE860 to participate, download slides and supporting materials, comp...
Mark Awad, MD, PhD - Advancing the Therapeutic Landscape of SCLC with B7-H3–Targeted Antibody-Drug Conjugates: Insights and Future Directions
09 Sep 2024
Contributed by Lukas
Please visit answersincme.com/BXP860 to participate, download slides and supporting materials, comp...
Aditya Bardia, MD - From Theory to Practice: Enhancing Antibody-Drug Conjugate Integration in HER2-Low Advanced Breast Cancer
09 Aug 2024
Contributed by Lukas
Please visit answersincme.com/TBW860 to participate, download slides and supporting materials, comp...
John L. Marshall, MD - Proactive Safety Management Strategies to Extend Survival for Patients With Metastatic CRC
09 Aug 2024
Contributed by Lukas
Please visit answersincme.com/ZVJ860 to participate, download slides and supporting materials, comp...
Rami Komrokji, MD - Navigating the First-Line Treatment Landscape of Anemia in Lower-Risk MDS: Translating the Latest Data to Practice
05 Aug 2024
Contributed by Lukas
Please visit answersincme.com/VWG860 to participate, download slides and supporting materials, comp...
Stephanie E. Combs, MD / Heather Wakelee, MD - A Growing Need for Targeted Approaches in Unresectable Stage III NSCLC: A Clinical Evaluation of Evolving Data in EGFR Mutation–Positive Disease
05 Aug 2024
Contributed by Lukas
Please visit answersincme.com/CFN860 to participate, download slides and supporting materials, comp...
Luis Paz-Ares, MD, PhD - Exploring the Potential of TROP2 ADCs for Advanced/Metastatic NSCLC: Implications for Practice
12 Jul 2024
Contributed by Lukas
Please visit answersincme.com/YSV860 to participate, download slides and supporting materials, comp...
Chris Verslype, MD, PhD - Optimizing TKI Therapy for Individualized Advanced HCC Treatment: Taking a Real-World Perspective
12 Jul 2024
Contributed by Lukas
Please visit answersincme.com/UYD860 to participate, download slides and supporting materials, comp...
Sagar Lonial, MD, FACP - Accelerating Targeted Degradation in Multiple Myeloma: The Role of CELMoDs in Overcoming IMiD Resistance in Earlier Lines of Therapy
04 Jul 2024
Contributed by Lukas
Please visit answersincme.com/DMQ860 to participate, download slides and supporting materials, comp...
Paul Telfer, MA, DM, BM, BCh, FRCP, FRCPath - Decoding the Future: Bringing Gene Therapy Into Prime Time for Patients With Sickle Cell Disease
04 Jul 2024
Contributed by Lukas
Please visit answersincme.com/HRY860 to participate, download slides and supporting materials, comp...
Ghassan Abou-Alfa, MD, MBA - Getting On the Right Tract: Patient-Centered Strategies to Diagnose Biliary Tract Cancers
04 Jul 2024
Contributed by Lukas
Please visit answersincme.com/CKZ860 to participate, download slides and supporting materials, comp...
Ticiana Leal, MD - Squaring Off With Squamous NSCLC: The Latest Evidence and Guidance on Chemoimmunotherapy Options
04 Jul 2024
Contributed by Lukas
Please visit answersincme.com/UWE860 to participate, download slides and supporting materials, comp...
Saad Z. Usmani, MD, MBA, FACP, FASCO - Making the Case for Triple Therapy in R/R Multiple Myeloma: Expert Guidance for Optimizing Anti-CD38 mAb Regimens
25 Jun 2024
Contributed by Lukas
Please visit answersincme.com/AEP860 to participate, download slides and supporting materials, comp...
Ben Carpenter, MD, PhD - Exploring Novel Therapeutic Frontiers in Transfusion-Dependent Beta Thalassemia: The Path to Transfusion Independence
25 Jun 2024
Contributed by Lukas
Please visit answersincme.com/VMK860 to participate, download slides and supporting materials, comp...
Josep M. Llovet, MD, PhD - Redefining How to Treat Intermediate-Stage HCC: Exploring TACE Plus Immunotherapy–Based Combination Therapy
18 Jun 2024
Contributed by Lukas
Please visit answersincme.com/SWS860 to participate, download slides and supporting materials, comp...
Richard Kim, MD - Enhancing Treatment Sequencing to Extend Survival: Tailoring Later-Line Care to the Patient With Metastatic Colorectal Cancer
28 May 2024
Contributed by Lukas
Please visit answersincme.com/TSH860 to participate, download slides and supporting materials, comp...
Jyoti Mayadev, MD - From Routine Screening to Applying Clinical Advances in Locally Advanced Cervical Cancer: Evolving Care in High-Risk Populations
30 Apr 2024
Contributed by Lukas
Please visit answersincme.com/YFE860 to participate, download slides and supporting materials, comp...
Geoffrey Ku, MD, MBA - Conversations in Precision Oncology: Harnessing Testing to Drive Personalized Treatment in HER2-Positive Advanced Gastric Cancer
05 Apr 2024
Contributed by Lukas
Please visit answersincme.com/DDF860 to participate, download slides and supporting materials, comp...
Peter Lio, MD - Generative AI: Benefits for Your Practice, for Your Patients
05 Apr 2024
Contributed by Lukas
Please visit answersincme.com/XGU860 to participate, download slides and supporting materials, comp...
Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician
05 Apr 2024
Contributed by Lukas
Please visit answersincme.com/WZP860 to participate, download slides and supporting materials, comp...
Aditya Bardia, MD - Endocrine Sensitivity in the Real World: Practical Guidance to Optimize Second-Line Care in ER-Positive, HER2-Negative Advanced Breast Cancer
29 Mar 2024
Contributed by Lukas
Please visit answersincme.com/GTJ860 to participate, download slides and supporting materials, comp...
Martin C. Mahoney, MD, PhD - Reducing the Burden of HPV-Related Cancers: Strategies for Improving HPV Vaccine Uptake in Males
29 Mar 2024
Contributed by Lukas
Please visit answersincme.com/XXZ860 to participate, download slides and supporting materials, comp...
Laura Spring, MD - The Patient-Clinician Alliance to Enhance Care for Patients With Metastatic Breast Cancer on Antibody-Drug Conjugates
25 Mar 2024
Contributed by Lukas
Please visit answersincme.com/MVB860 to participate, download slides and supporting materials, comp...
Heather Wakelee, MD - Stepping Up Clinical Outcomes for Resectable NSCLC: Examining the Role of Neoadjuvant Plus Adjuvant Immunotherapy Regimens
14 Mar 2024
Contributed by Lukas
Please visit answersincme.com/TAR860 to participate, download slides and supporting materials, comp...
Sue S. Yom, MD, PhD - Latest Updates in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Clinical Potential of Inhibitor of Apoptosis Protein (IAP) Antagonists to Change the Treatment Landscape
08 Mar 2024
Contributed by Lukas
Please visit answersincme.com/PQD860 to participate, download slides and supporting materials, comp...
Steven M. Horwitz, MD - Advancing The Treatment Paradigm in Relapsed/Refractory B- and T-Cell Lymphoma: The Evolving Role of EZH1/2 Pathway Inhibitors
06 Mar 2024
Contributed by Lukas
Please visit answersincme.com/HRM860 to participate, download slides and supporting materials, comp...
Stephen M. Ansell, MD, PhD / Caron Jacobson, MD, MMSc - Navigating a New Treatment Algorithm for Patients With Relapsed/Refractory Follicular Lymphoma: Where Do CD20 x CD3 Bispecific Antibodies Fit In?
26 Feb 2024
Contributed by Lukas
Please visit answersincme.com/XHR860 to participate, download slides and supporting materials, comp...
Nikhil I. Khushalani, MD - Pointing the Way to Enhanced Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Practical Strategies to Incorporate Neoadjuvant Immunotherapy
26 Feb 2024
Contributed by Lukas
Please visit answersincme.com/GXJ860 to participate, download slides and supporting materials, comp...
Susana M. Campos, MD, MPH - Expanding the Potential of HER2-Directed Antibody-Drug Conjugates: Evidence and Application in New Tumor Types
22 Feb 2024
Contributed by Lukas
Please visit answersincme.com/GXD860 to participate, download slides and supporting materials, comp...
Evan J. Lipson, MD - Real Talk About Maximizing Care in Advanced Melanoma: Balancing Benefit and Risk Using Dual Immunotherapy Regimens
14 Feb 2024
Contributed by Lukas
Please visit answersincme.com/AUY860 to participate, download slides and supporting materials, comp...
John N. Allan, MD - Enhancing Patient Outcomes in Relapsed/Refractory Follicular Lymphoma: Recognizing the Role of Novel Bispecific Antibody–Based Therapies
14 Feb 2024
Contributed by Lukas
Please visit answersincme.com/NRW860 to participate, download slides and supporting materials, comp...
Peter R. Galle, MD, PhD - Assembling a Long-Term Sequential Plan for Unresectable HCC: Practical Guidance for Improving Real-World Outcomes
10 Jan 2024
Contributed by Lukas
Please visit answersincme.com/EFR860 to participate, download slides and supporting materials, comp...
Tanya Siddiqi, MD - Addressing Patient Needs With CAR T-Cell Therapy in the Treatment of CLL/SLL: Preparing for an Evolving Treatment Paradigm
03 Jan 2024
Contributed by Lukas
Please visit answersincme.com/DTC860 to participate, download slides and supporting materials, comp...
David M. Miller, MD, PhD / Kevin Emerick, MD - Coming Together to Improve Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Multidisciplinary Care Strategies With Neoadjuvant Immunotherapy
03 Jan 2024
Contributed by Lukas
Please visit answersincme.com/ADB860 to participate, download slides and supporting materials, comp...
Manish A. Shah, MD - Keeping Current on Frontline Immunotherapy-Chemotherapy Combinations: HER2-Positive and HER2-Negative Unresectable Advanced Gastric or GEJ Adenocarcinoma
29 Dec 2023
Contributed by Lukas
Please visit answersincme.com/QHX860 to participate, download slides and supporting materials, comp...
Adam Brufsky, MD, PhD - Getting Real With Patients During Clinical Decision-Making: The Value of Sharing Real-World Evidence About CDK4/6 Inhibitors for HR+/HER2- Metastatic Breast Cancer
18 Dec 2023
Contributed by Lukas
Please visit answersincme.com/VVM860 to participate, download slides and supporting materials, comp...
Patrick Forde, MB, BCh - Keeping the Dialogue Open in Early-Stage NSCLC: Instituting a Multidisciplinary Approach
18 Dec 2023
Contributed by Lukas
Please visit answersincme.com/GSN860 to participate, download slides and supporting materials, comp...
Vishal A. Patel, MD - Making Headway in Treating Resectable Cutaneous Squamous Cell Carcinoma: Setting Sights on Neoadjuvant Immunotherapy
18 Dec 2023
Contributed by Lukas
Please visit answersincme.com/JEX860 to participate, download slides and supporting materials, comp...
Josep M. Llovet, MD, PhD - Enhancing Long-Term Survival in Unresectable HCC: Optimizing First-Line Immunotherapy-Based Combination Regimens
18 Dec 2023
Contributed by Lukas
Please visit answersincme.com/TAJ860 to participate, download slides and supporting materials, comp...
Wolfgang Miesbach, MD, PhD - Gene Therapy in Hemophilia A: Redefining the Treatment Paradigm
05 Dec 2023
Contributed by Lukas
Please visit answersincme.com/MWD860 to participate, download slides and supporting materials, comp...
Jorge Cortes, MD - Third-Line Therapies in Chronic Myeloid Leukemia: Evolving to Overcome the Limitations of Early-Generation Tyrosine Kinase Inhibitors
13 Nov 2023
Contributed by Lukas
Please visit answersincme.com/RPM860 to participate, download slides and supporting materials, comp...
Asa Radix, MD, PhD, MPH - A Call to Action to Prevent Cervical Cancer in Transgender and Nonbinary Populations: Patient-Centered Strategies to Increase Screening Rates
31 Oct 2023
Contributed by Lukas
Please visit answersincme.com/UJD860 to participate, download slides and supporting materials, comp...
Trisha Wise-Draper, MD, PhD - Empowering Precision Decisions: PD-1 Inhibitor-Based Therapies and Biomarker Testing in R/M HNSCC
11 Oct 2023
Contributed by Lukas
Please visit answersincme.com/EXA860 to participate, download slides and supporting materials, comp...
Richard Finn, MD - Improving Patient Outcomes in Advanced Biliary Tract Cancer: Evaluating the Promise of Immunotherapy Plus Chemotherapy Combinatorial Approaches
25 Sep 2023
Contributed by Lukas
Please visit answersincme.com/EKH860 to participate, download slides and supporting materials, comp...
Matthew R. Smith, MD, PhD - Combined Systemic Therapy to Combat Metastatic Hormone-Sensitive Prostate Cancer
22 Sep 2023
Contributed by Lukas
Please visit answersincme.com/WGA860 to participate, download slides and supporting materials, comp...
Joshua Richter, MD / Saad Z. Usmani, MD, MBA, FACP - Optimizing Patient Outcomes in Relapsed/Refractory Multiple Myeloma: The Role of Novel BCMA-Targeted Bispecific Antibodies
19 Sep 2023
Contributed by Lukas
Please visit answersincme.com/GQB860 to participate, download slides and supporting materials, comp...
Sapna P. Patel, MD - Enhancing Neoadjuvant and Adjuvant Treatment in Resectable Melanoma: Is Timing the Key to Improved Outcomes?
19 Sep 2023
Contributed by Lukas
Please visit answersincme.com/CAC860 to participate, download slides and supporting materials, comp...
Alexander I. Spira, MD, PhD, FACP - Breaking News in NSCLC: The Latest Evidence on Emerging Antibody Drug Conjugates Targeting TROP2
05 Sep 2023
Contributed by Lukas
Please visit answersincme.com/DEV860 to participate, download slides and supporting materials, comp...
Eric K. Singhi, MD / Charu Aggarwal, MD, MPH - It Takes Two to Tango: Exploring the Clinical Implications of First-Line Immunotherapy Plus Chemotherapy Combinations in Advanced NSCLC
05 Sep 2023
Contributed by Lukas
Please visit answersincme.com/ZRV860 to participate, download slides and supporting materials, comp...
Jamie E. Chaft, MD - Enhancing Outcomes for Patients With Resected, Early-Stage NSCLC: A Piercing Evaluation of the Clinical Support for Adjuvant Immunotherapies
23 Aug 2023
Contributed by Lukas
Please visit answersincme.com/VET860 to participate, download slides and supporting materials, comp...
Stephen Lam Chan, MD - Recalibrating Survival: Available and Recently Approved Immunotherapy-Based Combination Approaches in Unresectable HCC
17 Aug 2023
Contributed by Lukas
Please visit answersincme.com/TZQ860 to participate, download slides and supporting materials, comp...
Eric Jonasch, MD - Optimizing Long-Term Care With Guideline-Recommended Systemic Treatment Options for von Hippel-Lindau Disease-Associated Renal Cell Carcinoma
27 Jul 2023
Contributed by Lukas
Please visit answersincme.com/XJR860 to participate, download slides and supporting materials, comp...
Enriqueta Felip, MD, PhD / David Harpole, MD - Reflecting on the Role of Perioperative Immunotherapeutic Regimens for Resectable Non–Small-Cell Lung Cancer: Evaluating the Evidence to Determine Better Pathways of Care
27 Jul 2023
Contributed by Lukas
Please visit answersincme.com/XQE860 to participate, download slides and supporting materials, comp...
Saad Z. Usmani, MD, MBA, FACP / Gareth J. Morgan, MD, PhD - Strength in Numbers: Triplet Combination Therapies in Relapsed/Refractory Multiple Myeloma (RRMM) Special Patient Populations
07 Jul 2023
Contributed by Lukas
Please visit answersincme.com/MMD860 to participate, download slides and supporting materials, comp...